Healthcare

The US Food and Drug Administration (FDA) has approved ibrexafungerp tablets (Brexafem) as a 1-day oral therapy for vaginal yeast infections, it is estimated that 3 out of every 4 women face at least once in their life. Ibrexafungerp is the first drug approved in a new antifungal class for ...

The US Food and Drug Administration (FDA) has approved ozanimod (Zeposia) for adults who suffer from moderate to active ulcerative colitis (UC), the company announced. Ozanimod’s approval for UC is based on data from True North, a phase 3 placebo-controlled trial that evaluated medication in 645 adults (mean age, 42 ...

WHO – The US Food and Drug Administration (FDA) approved Rybrevant (Amivanthamb-vmjw) on 21 May, as the primary treatment for adult patients with non-small cell lung cancer, whose tumors have specific types of genetic mutations: epidermal growth factor receptor (EGFR) ) Exon 20 insertion mutation. The FDA also approved Guardant360 ...

WORLD – World Health Organization (WHO) official says that COVID-19 vaccines authorized for use in the United States and Europe provide protection against all known coronavirus variants. WHO European Regional Director Hans Kluge said at a press conference on Thursday, “All COVID-19 virus variants that have emerged so far do ...

Taiwan is troubled by the second wave of coronavirus infection. Especially in the capital Taipei, there has been a steady increase in the number of newly infected people in the last week. On Monday, this number reached 335. On Sunday, 207 new cases were reported. In view of this, many ...

According to a report by the American Academy of Pediatrics and Children’s Hospital Association, after declining for 2 consecutive weeks, the number of new COVID-19 cases in children increased slightly. This increase was less than 0.6% – 72,067 cases reported during the week of 30 April to 6 May, compared ...

The Food and Drug Administration (FDA), at the request of Pfizer and BioNTech, allowed its COVID-19 vaccine to be given to children between 12 and 15 years of age on emergency use on Monday. The much-awaited decision raises the possibility that schools in the United States will reopen completely in ...

The chief scientist Soumya Swaminathan from WHO blamed huge social mixing and large gatherings as responsible for the massive second wave. AFP reported that World Health Organization (WHO) chief scientist Soumya Swaminathan said on Saturday that the coronavirus variant spreading in India was more contagious and contained some mutations that ...

According to the first results released on Wednesday by Moderna Inc., a biotechnology company, the modern SARS-CoV-2 vaccine booster is specifically developed with the variant B.1.351 demonstrates efficacy against that strain and the P1 variant in those already vaccinated for COVID-19. In addition, the company’s ongoing Phase 2 study demonstrates ...

The Bajaj Healthcare Limited (BHL) has successfully developed and received approval from India’s drug regulator to distributed “Favijaj” tablet in the market to treat COVID-19 patients from May 4, 2021. Pharmaceutical company Bajaj Healthcare Limited (BHL) has announced on Tuesday the launch of antiviral Favipiravir tablet with brand name “Favijaj”. ...